Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19
Condition:   Coronavirus Infections Interventions:   Drug: tixagevimab/cilgavimab 150+150 mg;   Drug: tixagevimab/cilgavimab 300+300 mg;   Drug: regdanvimab Sponsors:   City Clinical Hospital No.52 of Moscow Healthcare Department;   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials

Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation
Conditions:   Lung Transplant Infection;   Molecular Diagnostic;   Bacterial Infections;   Pneumonia;   Tracheobronchitis Intervention:   Diagnostic Test: BioFire Pneumonia Panel Plus Sponsor:   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials